A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring.

cancer eHealth electronic patient-reported outcomes ethics quality of care quality of life self-management survivorship symptoms

Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
17 06 2022
Historique:
received: 28 03 2022
revised: 11 05 2022
accepted: 31 05 2022
entrez: 23 6 2022
pubmed: 24 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Electronic patient-reported outcome (ePRO) applications promise great added value for improving symptom management and health-related quality of life. The aim of this narrative review is to describe the collection and use of ePROs for cancer survivorship care, with an emphasis on ePRO-symptom monitoring. It offers many different perspectives from research settings, while current implementation in routine care is ongoing. ePRO collection optimizes survivorship care by providing insight into the patients' well-being and prioritizing their unmet needs during the whole trajectory from diagnosis to end-of-life. ePRO-symptom monitoring can contribute to timely health risk detection and subsequently allow earlier intervention. Detection is optimized by automatically generated alerts that vary from simple to complex and multilayered. Using ePRO-symptoms during in-hospital consultation enhances the patients' conversation with the health care provider before making informed decisions about treatments, other interventions, or self-management. ePRO(-symptoms) entail specific implementation issues and complementary ethics considerations. The latter is due to privacy concerns, digital divide, and scarcity of adequately representative data for particular groups of patients.

Identifiants

pubmed: 35735458
pii: curroncol29060349
doi: 10.3390/curroncol29060349
pmc: PMC9222072
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4370-4385

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Eur J Oncol Nurs. 2018 Jun;34:35-41
pubmed: 29784136
Cancer Med. 2020 Oct;9(19):7107-7115
pubmed: 32794634
Patient. 2018 Dec;11(6):591-598
pubmed: 29968179
Pilot Feasibility Stud. 2018 Jun 05;4:110
pubmed: 29992040
JMIR Cancer. 2018 Dec 21;4(2):e10932
pubmed: 30578238
Cancer Med. 2017 Mar;6(3):537-546
pubmed: 28135050
JCO Clin Cancer Inform. 2020 Oct;4:947-957
pubmed: 33112661
J Eval Clin Pract. 2020 Apr;26(2):524-540
pubmed: 31840346
BMC Cancer. 2020 Jun 10;20(1):543
pubmed: 32522163
JAMA. 2019 Jan 22;321(3):306-307
pubmed: 30667494
BMC Cancer. 2012 Jul 20;12:300
pubmed: 22817614
J Natl Cancer Inst. 2021 May 4;113(5):523-531
pubmed: 32525530
Support Care Cancer. 2021 Apr;29(4):1723-1739
pubmed: 33058000
Eur J Oncol Nurs. 2020 Feb;44:101714
pubmed: 31954227
Lancet Oncol. 2020 Jan;21(1):80-94
pubmed: 31838009
Qual Life Res. 2021 Nov;30(11):3015-3033
pubmed: 32651805
Cureus. 2020 Aug 31;12(8):e10156
pubmed: 33014652
Cancer Nurs. 2021 Mar-Apr 01;44(2):87-88
pubmed: 33587491
BMJ Open. 2021 Sep 13;11(9):e052494
pubmed: 34518276
Ann Oncol. 2017 Sep 01;28(9):2305-2311
pubmed: 28911065
Health Mark Q. 2008;25(1-2):175-203
pubmed: 18935884
Qual Life Res. 2021 Nov;30(11):3241-3254
pubmed: 33052514
BMJ. 2021 Jul 21;374:n1647
pubmed: 34289996
JAMA Oncol. 2020 Feb 1;6(2):e193332
pubmed: 31556911
Qual Life Res. 2012 Sep;21(7):1159-64
pubmed: 21984468
J Patient Rep Outcomes. 2020 Nov 26;4(1):101
pubmed: 33242136
J Natl Cancer Inst. 2009 Dec 2;101(23):1624-32
pubmed: 19920223
Med J Aust. 2021 May;214(9):406-408.e1
pubmed: 34046907
Health Promot J Austr. 2021 Feb;32 Suppl 1:104-114
pubmed: 32681656
Support Care Cancer. 2020 Apr;28(4):1725-1735
pubmed: 31297593
J Thorac Oncol. 2019 Jun;14(6):1012-1020
pubmed: 30776447
Adolesc Health Med Ther. 2015 Aug 18;6:141-8
pubmed: 26316835
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28423407
Support Care Cancer. 2009 Apr;17(4):437-44
pubmed: 18953579
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
BMC Cancer. 2019 May 17;19(1):463
pubmed: 31101017
J Patient Rep Outcomes. 2020 Jun 17;4(1):47
pubmed: 32556794
J Pain Symptom Manage. 2017 Mar;53(3):630-643
pubmed: 28042071
Support Care Cancer. 2021 Jan;29(1):7-10
pubmed: 32844316
Support Care Cancer. 2021 Aug;29(8):4239-4247
pubmed: 33411044
BMC Cancer. 2017 May 8;17(1):318
pubmed: 28482877
J Clin Oncol. 2013 Jul 20;31(21):2699-707
pubmed: 23775951
J Med Internet Res. 2019 Jan 24;21(1):e10875
pubmed: 30679145
Support Care Cancer. 2020 Oct;28(10):4933-4942
pubmed: 32020357
Eur J Cancer Care (Engl). 2019 May;28(3):e13095
pubmed: 31090160
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
J Natl Cancer Inst. 2011 Dec 21;103(24):1808-10
pubmed: 22157639
BMC Cancer. 2019 Sep 5;19(1):884
pubmed: 31488084
J Clin Oncol. 2011 Mar 10;29(8):994-1000
pubmed: 21282546
Eur J Oncol Nurs. 2017 Dec;31:37-45
pubmed: 29173825
Oncologist. 2019 Nov;24(11):e1219-e1227
pubmed: 31409744
Support Care Cancer. 2020 Feb;28(2):713-723
pubmed: 31129760
Eur J Cancer. 2011 Sep;47(14):2188-94
pubmed: 21621408
JAMA Oncol. 2020 Mar 1;6(3):437-439
pubmed: 31876902
J Patient Rep Outcomes. 2018 Oct 03;2:46
pubmed: 30363333
J Patient Rep Outcomes. 2020 Jul 16;4(1):58
pubmed: 32676785
Lancet Digit Health. 2021 Apr;3(4):e260-e265
pubmed: 33678589
Support Care Cancer. 2021 Feb;29(2):573-593
pubmed: 32875373
J Cancer Educ. 2017 Jun;32(2):228-237
pubmed: 26854084
J Med Internet Res. 2017 Aug 15;19(8):e288
pubmed: 28811271
Clin Trials. 2021 Feb;18(1):104-114
pubmed: 33258687
J Cancer Surviv. 2020 Aug;14(4):504-517
pubmed: 32162194
EGEMS (Wash DC). 2015 Oct 29;3(1):1169
pubmed: 26557724
J Cancer Surviv. 2021 Apr;15(2):201-212
pubmed: 32865766
J Med Internet Res. 2015 Apr 01;17(4):e86
pubmed: 25842005
Trials. 2017 Apr 28;18(1):199
pubmed: 28454583
Support Care Cancer. 2019 Sep;27(9):3411-3419
pubmed: 30656400
BMC Palliat Care. 2020 Sep 9;19(1):139
pubmed: 32907564
Cancer Nurs. 2021 Nov-Dec 01;44(6):E687-E702
pubmed: 34507338
Cancers (Basel). 2021 Aug 25;13(17):
pubmed: 34503092
Support Care Cancer. 2021 Jun;29(6):3401-3408
pubmed: 33515304
J Natl Cancer Inst. 2022 Jun 13;114(6):800-807
pubmed: 35201353
Cancer. 2021 Aug 15;127(16):2980-2989
pubmed: 33945640
J Med Internet Res. 2021 Dec 14;23(12):e27886
pubmed: 34904948
Value Health. 2019 Oct;22(10):1197-1226
pubmed: 31563263
J Patient Rep Outcomes. 2020 Apr 25;4(1):27
pubmed: 32335745

Auteurs

Corina J G van den Hurk (CJG)

Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.

Floortje Mols (F)

Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.
CoRPS-Center of Research on Psychological Disorders and Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, 5037 AB Tilburg, The Netherlands.

Manuela Eicher (M)

Institute of Higher Education and Research in Health Care (IUFRS), Faculty of Biology and Medicine, University of Lausanne and Lausanne University Hospital, CH-1010 Lausanne, Switzerland.
Department of Oncology, Lausanne University Hospital, CH-1011 Lausanne, Switzerland.

Raymond J Chan (RJ)

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, SA 5042, Australia.

Annemarie Becker (A)

Amsterdam UMC, Department of Pulmonary Diseases, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.

Gijs Geleijnse (G)

Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.

Iris Walraven (I)

Radboudumc, Department for Health Evidence, 6525 GA Nijmegen, The Netherlands.

Annemarie Coolbrandt (A)

Department of Oncology Nursing, University Hospitals Leuven, 3000 Leuven, Belgium.
Department of Public Health and Primary Care, Academic Center for Nursing and Midwifery, 3000 Leuven, Belgium.

Maryam Lustberg (M)

Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA.
Breast Center at Smilow Cancer Hospital, New Haven, CT 06519, USA.

Galina Velikova (G)

Leeds Institute of Medical Research at St James's, University of Leeds and Leeds Cancer Centre, St James's University Hospital, Leeds LS9 7TF, UK.

Andreas Charalambous (A)

Nursing Department, Cyprus University of Technology, Limassol 3036, Cyprus.
Department of Nursing Science, University of Turku, 00074 CGI Turku, Finland.

Bogda Koczwara (B)

Flinders Medical Centre, Flinders University, Adelaide, SA 5042, Australia.

Doris Howell (D)

Princess Margaret Cancer Research Institute, University of Toronto, Toronto, ON M5G 2M9, Canada.

Ethan M Basch (EM)

Lineberger Comprehensive Cancer Center, University of North Carolina Cancer Center, Chapel Hill, NC 27599, USA.

Lonneke V van de Poll-Franse (LV)

Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.
CoRPS-Center of Research on Psychological Disorders and Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, 5037 AB Tilburg, The Netherlands.
Department of Psychosocial Research, Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH